期刊文献+

骨肉瘤免疫疗法的研究进展

Advances in osteosarcoma immunotherapy
下载PDF
导出
摘要 骨肉瘤发病率在儿童和青少年恶性肿瘤中居首位,肺部转移率高,仅行手术治疗的患者存活率较低。免疫疗法具有肿瘤免疫杀伤特异性,被认为是最有可能提高癌症患者生存率的治疗方法之一,可作为骨肉瘤新的治疗方向。本文就骨恶性肿瘤的生物学特点、骨肉瘤肺部转移的机制以及免疫疗法的机制进行综述。
作者 黄重 贾瑞鹏 钟海琳 符策岗 HUANG zhong;JIA Rui-peng;ZHONG Hai-lin
出处 《广西医学》 CAS 2020年第3期347-350,374,共5页 Guangxi Medical Journal
  • 相关文献

参考文献2

二级参考文献42

  • 1魏玲,宋现让,王兴武,李敏,左文述.MDR1和GST-π在骨软组织肉瘤中的表达及其与化疗耐药的关系[J].中华肿瘤杂志,2006,28(6):445-448. 被引量:15
  • 2Chou AJ, Gorlick R. Chemotherapy resistance in osteosarcoma: current challenges and future directions [ J ]. Expert Rev Antican- cer There, 2006, 6(7): 1075-1085.
  • 3Longhi A, Errani C, De Paolis M, et al. Primary bone osteosareo- ma in the pediatric age : state of the art [ J ]. Cancer Treat Rev, 2006, 32(6) : 423 -436.
  • 4Chou A J, Geller DS, Gorliek R. Therapy for osteosarcoma: where do we go from here? [J]. Paediatr Drugs, 2008, 10(5) : 315 - 327.
  • 5Eilber FR, Rosen G. Adjuvant chemotherapy for osteosareoma [J]. Semin Oncol, 1989, 16(4) : 312 -322.
  • 6Sakamoto A, Iwamoto Y. Current status and perspectives regarding the treatment of osteosarcoma: chemotherapy[ J]. Rev Recent Clin Trials, 2008, 3 (3) : 228 - 231.
  • 7He HT, Ni JD, Huang J. Molecular mechanisms of chemoresis- tance in osteosarcoma (Review) [J]. Oncol Lett, 2014, 7 (5) : 1352 - 1362.
  • 8Meric- Bernstam F, Gonzalez - Angulo AM. Targeting the mTOR signaling network for cancer therapy[ J]. J Clin Oneol, 2009, 27 ( 13 ) : 2278 - 2287.
  • 9Gazitt Y, Kolapathi V, Moncada K, et al. Targeted therapy of hu- man osteosarcoma with 17AAG or rapamycin: characterization of induced apoptosis and inhibition of mTOR and Akt/MAPK/Wnt pathways[Jl. Int J Oneol, 2009, 34(2) : 551 -561.
  • 10Houghton PJ, Morton CL, Kolb EA, et al. Initial testing (stage 1 ) of the roTOR inhibitor rapamycin by the pediatric preclinical testing program[J]. Pediatr Blood Cancer, 2008, 50(4): 799- 805.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部